43 results
424B5
ICON Operational Financing Unlimited Co
2 May 24
Prospectus supplement for primary offering
10:16am
to variable, and accelerate time to market for new treatments.
We believe regulatory and reimbursement pressures will increase the emphasis on late stage … and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe advances
424B5
ICON Operational Financing Unlimited Co
26 Apr 24
Prospectus supplement for primary offering
9:41am
in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.
We believe regulatory and reimbursement … reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn
6-K
EX-99.1
ICLR
Icon Plc
25 Apr 24
Third Amendment to Credit Agreement
4:32pm
Disbursements which are the subject of a borrowing, drawing, payment, reimbursement or rate selection are denominated in euros, the term “Business Day” shall also … or in respect of any of the Loans made or reimbursement or other obligations incurred or any of the Letters of Credit or other instruments at any time
6-K
EX-99.3
ICLR
Icon Plc
12 Jun 23
Notice of Annual General Meeting
8:07am
in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.
Regulatory and reimbursement … reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should
6-K
EX-99.3
kqkfk3u2vzua7bljyovc
17 Jun 22
Notice of Annual General Meeting
9:12am
6-K
l2noyj
9 Nov 21
Current report (foreign)
4:23pm
6-K
z98217
23 Jul 21
Current report (foreign)
8:21am
6-K
EX-99.1
j6yq5v23ol v01kt
21 Jul 21
Icon PLC 6-K
4:20pm
6-K
EX-99.2
jw0tbnqlydslkm
1 Jul 21
Current report (foreign)
8:54am
6-K
EX-99.1
teygtgmirhep27lf96
1 Jul 21
Current report (foreign)
8:54am
6-K
EX-99.3
tg8hv2m4 k9t3u8m8
16 Jun 21
Notice of Annual General Meeting
4:16pm
6-K
8rxqw6cf
30 Apr 21
Current report (foreign)
6:18am
424B3
ids4xfo56iwx0j
28 Apr 21
Prospectus supplement
12:00am
F-4/A
zdu7hss4g3
26 Apr 21
Registration of securities (foreign) (amended)
9:11pm
F-4
yuqtjy77c59awz95
31 Mar 21
Registration of securities (foreign)
9:09am
425
EX-2.1
761nm1wor ileo0g
24 Feb 21
Business combination disclosure
5:23pm
425
tmqu 27o7vwxyzqb
24 Feb 21
Business combination disclosure
5:23pm
6-K
n4b9wegr
24 Feb 21
ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research
4:21pm